New 3D map may help surgeons remove lung cancer more accurately

NCT ID NCT06952894

Completed Knowledge-focused Sponsor: Hutom Corp Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a software tool called RUS Lung that creates a 3D model of a patient's lungs from CT scans. Surgeons used it to plan and guide minimally invasive surgery for early-stage lung cancer. The study enrolled 34 adults and checked how well the tool matched the actual tumor location during surgery. The goal was to see if the tool is feasible and helpful, not to prove it improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RUS Lung (a 3D surgical navigation software)
What this could lead to: If successful, this tool could help surgeons perform lung cancer surgery more precisely, potentially improving outcomes and reducing complications.
What could go wrong: This was a small, early-stage study with only 34 participants and no comparison group, so results may not apply broadly. The tool is just a planning aid, not a treatment itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Show contact details

Locations

Severance Hospital

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.